» Articles » PMID: 12020185

Effect of Postthrombotic Syndrome on Health-related Quality of Life After Deep Venous Thrombosis

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2002 May 22
PMID 12020185
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Postthrombotic syndrome (PTS) is a frequent chronic complication of deep venous thrombosis, yet its impact on health-related quality of life has not been well characterized. We compared generic and venous disease-specific quality of life in patients with and without PTS, and assessed whether quality of life correlated with severity of PTS.

Methods: Subjects with previous deep venous thrombosis were participants in a study of the effects of exercise after deep venous thrombosis. We ascertained PTS and its severity using a validated clinical scale. Subjects completed generic (the 36-Item Short-Form Health Survey) and disease-specific (Venous Insufficiency Epidemiologic and Economic Study quality-of-life questionnaire [VEINES-QOL] and its validated subscale of 10 items on venous symptoms [VEINES-Sym]) quality-of-life measures. Age- and sex-adjusted mean quality-of-life scores were compared in patients with and without PTS, and by severity of PTS.

Results: Of the 41 subjects (mean age, 51.2 years), 19 (46%) had PTS. Subjects with PTS had significantly worse disease-specific quality-of-life scores than those without PTS (mean +/- SD VEINES-QOL score, 44.5 +/- 11.6 vs 54.8 +/- 5.4, respectively [P<.001]; mean +/- SD VEINES-Sym score, 45.6 +/- 11.4 vs 54.1 +/- 6.7, respectively [P =.003]), which worsened significantly with increasing severity of PTS. We found no differences in generic quality-of-life scores between subject groups.

Conclusions: Postthrombotic syndrome has a significant impact on disease-specific quality of life that may not be captured by generic quality-of-life measures. Patient-based quality-of-life measures correlated well with physician-assessed PTS. Further research is indicated to assess the value of including quality of life as a routine measure of outcome in clinical studies of patients with deep venous thrombosis and PTS.

Citing Articles

Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus.

Haladyj E, Matusiewicz A, Wysocki T, Olesinska M Reumatologia. 2024; 62(4):266-273.

PMID: 39381730 PMC: 11457315. DOI: 10.5114/reum/192028.


Acute kidney injury requiring dialysis after endovascular intervention for acute deep venous thrombosis: A case report and literature review.

Al-Mannai N, Sibira D, Alsuwaidi H, Elmagdoub A, Habas E, Alfitori G Clin Case Rep. 2024; 12(10):e9263.

PMID: 39328294 PMC: 11423260. DOI: 10.1002/ccr3.9263.


Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review.

Attaran R, Carr J J Soc Cardiovasc Angiogr Interv. 2024; 2(1):100538.

PMID: 39132527 PMC: 11307564. DOI: 10.1016/j.jscai.2022.100538.


Ferumoxytol-enhanced MRI assessment of venous Thrombus resolution and macrophage content in a murine deep vein thrombosis model.

Morrison L, Smoody B, Woltjer R, Hinds M, Loftis J, Wyatt C Thromb Res. 2024; 240:109063.

PMID: 38878741 PMC: 11239555. DOI: 10.1016/j.thromres.2024.109063.


Fibrinogen levels and clot properties identify patients who benefit from catheter-directed thrombolysis after DVT.

Iding A, Alkarithi G, Ten Cate H, Ariens R, Ten Cate-Hoek A Blood Adv. 2024; 8(11):2924-2932.

PMID: 38547453 PMC: 11176944. DOI: 10.1182/bloodadvances.2023012493.